Hodgkin's disease in children.
This article discusses the presentation and evolution of therapy of pediatric Hodgkin's disease, contrasted with developments in adults. The issues of staging, treatment, and toxicity of radiotherapy, chemotherapy, and combined modality therapy are discussed. Recommendations for therapy are presented.
Pao
W J
WJ
Department of Radiation Oncology, St. Jude's Children's Research Hospital, Memphis, Tennessee.
Kun
L E
LE
D000293:Adolescent; D000367:Age Factors; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy / Q000009:adverse effects; D005060:Europe; D005260:Female; D006130:Growth Disorders / Q000209:etiology; D006689:Hodgkin Disease / Q000453:epidemiology / Q000473:pathology / Q000628:therapy*; D006801:Humans; D007037:Hypothyroidism / Q000209:etiology; D008297:Male; D009367:Neoplasm Staging; D009378:Neoplasms, Multiple Primary / Q000209:etiology; D011878:Radiotherapy / Q000009:adverse effects; D012737:Sex Factors; D013156:Splenectomy / Q000009:adverse effects; D014481:United States